| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lipocine Inc. (LPCN) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. LPCN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 203.8K | $474.8K | - | |
| CEO | 160.7K | $374.4K | - | |
| Other | 40.1K | $93.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Higuchi John W. | Director | Buy | 40,000 | $2.03 | $81,200.00 | +24.4% | - | - | |
| Apr 6, 2026 | Patel Mahesh V. | Chief Executive Officer | Buy | 25,000 | $2.03 | $50,750.00 | +18.4% | - | - | |
| Apr 6, 2026 | Higuchi John W. | Director | Buy | 123,000 | $2.05 | $252,150.00 | +301.5% | - | - | |
| May 25, 2023 | Patel Mahesh V. | CEO And President | Buy | 8,706 | $5.03 | $43,791.18 | +8.8% | -17.3% | +32.2% | |
| Mar 24, 2023 | Patel Mahesh V. | CEO And President | Buy | 150,000 | $0.32 | $48,000.00 | +9.8% | -1.5% | -20.1% | |
| Mar 20, 2023 | Ono Richard Dana | Director | Buy | 4,000 | $0.34 | $1,360.00 | +39.5% | -9.0% | -23.0% | |
| Mar 17, 2023 | Patel Mahesh V. | CEO And President | Buy | 50,000 | $0.33 | $16,500.00 | +3.4% | -14.9% | -22.2% | |
| Nov 22, 2022 | Papapetropoulos Spyros | Director | Buy | 21,739 | $0.47 | $10,217.33 | New | +5.7% | -68.4% | |
| Nov 14, 2022 | Patel Mahesh V. | CEO And President | Buy | 75,000 | $0.39 | $29,250.00 | +5.3% | +42.1% | -58.4% | |
| Sep 27, 2022 | Patel Mahesh V. | CEO And President | Buy | 100,000 | $0.41 | $41,000.00 | +7.7% | +2.0% | -56.5% |